EUVIMEDEUVIMED entdecken
Open Access

Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy

Xi Liu iD, Dinesh Dhumal iD, Patricia Santofimia-Castaño iD, Juan Liu iD, Marion Casanova iD, Alicia Comino Garcia-Muñoz iD, Teodora-Adriana Perles-Barbacaru iD, Abdechakour Elkihel iD, Wenzheng Zhang, Tom Roussel, Christina Galanakou, Jing Wu und 7 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adu9948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Xi Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), UMR 7325, Equipe Labellisée Ligue Contre le Cancer, 13…. Hauptthemen laut MEDLINE: Dendrimers, Ether-A-Go-Go Potassium Channels, ERG1 Potassium Channel, Nanoparticles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiotoxicity, especially human ether-a-go-go–related gene (hERG)–related toxicity, is a leading cause of drug failure or market withdrawal. Reducing hERG binding to obviate potential cardiac toxicity is crucial. Nanotechnology has been applied to drug delivery for reducing drug toxicity and improving efficacy, but few studies have addressed hERG-related cardiotoxicity. We report the use of self-assembling dendrimer nanosystems for drug formulation and delivery, which effectively reduced hERG binding and associated toxicity while promoting therapeutic efficacy. Specifically, these dendrimer nanosystems efficiently encapsulated the antimalarial drug chloroquine, the anticancer agent doxorubicin, and the NUPR1 inhibitor ZZW115, all three having high affinity to hERG channels. These nanoformulations showed three- to eightfold reduced hERG binding affinity, which, in animal models, translated to abolished toxicity. These nanodrugs exhibited prolonged circulation, leading to enhanced accumulation at disease sites and improved treatment outcomes. This study highlights the potential of nanotechnology to reduce hERG binding and related toxicity while improving drug efficacy, offering valuable perspectives for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DendrimersEther-A-Go-Go Potassium ChannelsERG1 Potassium ChannelNanoparticlesHumansAnimalsDoxorubicinMiceChloroquineCardiotoxicityDrug Delivery SystemsDrug Compounding

Substanzen

DendrimersDoxorubicinEther-A-Go-Go Potassium ChannelsERG1 Potassium ChannelChloroquineKCNH2 protein, human

Autor:innen und Institutionen

  • Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (CINaM), UMR 7325, Equipe Labellisée Ligue Contre le Cancer, 13288 Marseille, France.
  • Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS, UMR 7258, Institut Paoli-Calmettes, Aix Marseille Université, 13273 Marseille, France.
  • Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology of China, Beijing 100190, China.
  • Aix Marseille University, CNRS, Centre de Résonance Magnétique Biologique et Médicale (CRMBM), UMR 7339, 13385 Marseille, France.
  • Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, No. 55 Daxuecheng South Road, Chongqing 401331, P. R. China.

ORCID-Profile: Xi Liu, Dinesh Dhumal, Patricia Santofimia-Castaño, Juan Liu, Marion Casanova, Alicia Comino Garcia-Muñoz, Teodora-Adriana Perles-Barbacaru, Abdechakour Elkihel, Eleni Zerva, Nelson Dusetti, Yi Xia, Xing-Jie Liang, Angèle Viola, Juan L Iovanna, Ling Peng

Zitieren

APA

Liu, X., Dhumal, D., Santofimia-Castaño, P., Liu, J., Casanova, M., Garcia-Muñoz, A. C., Perles-Barbacaru, T. A., Elkihel, A., Zhang, W., Roussel, T., Galanakou, C., Wu, J., Zerva, E., Dusetti, N., Xia, Y., Liang, X. J., Viola, A., Iovanna, J. L., & Peng, L. (2025). Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy. Science Advances. https://doi.org/10.1126/sciadv.adu9948

Vancouver

Liu X, Dhumal D, Santofimia-Castaño P, Liu J, Casanova M, Garcia-Muñoz AC, et al. Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy. Science Advances. 2025. doi:10.1126/sciadv.adu9948

BibTeX
@article{Liu2025,
  author = {Liu, Xi and Dhumal, Dinesh and Santofimia-Castaño, Patricia and Liu, Juan and Casanova, Marion and Garcia-Muñoz, Alicia Comino and Perles-Barbacaru, Teodora-Adriana and Elkihel, Abdechakour and Zhang, Wenzheng and Roussel, Tom and Galanakou, Christina and Wu, Jing and Zerva, Eleni and Dusetti, Nelson and Xia, Yi and Liang, Xing-Jie and Viola, Angèle and Iovanna, Juan L and Peng, Ling},
  title = {Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adu9948}
}
Kostenlos starten →